Working together to advance cell manufacturing
CMaT will enable robust, scalable, low-cost biomanufacturing of high-quality theraputic cells to bring affordable, curative therapies against incurable chronic diseases.
A partnership with the National
Cell Manufacturing Consortium
Assays that can characterize MSC immune potency need to be identified for use in advanced clinical trials. MSCs possess a number of putative regenerative and immunomodulatory properties, and an assay matrix approach may best capture involved effector path
Petit Institute executive director among Georgia Tech winners at annual life sciences industry gala
“Near Infrared and Short Wave Radio Frequency Sensors for Wireless Biomanufacturing Process Analytics” - Nigel Reuel, Ph.D. Iowa State University